Spots Global Cancer Trial Database for hormonotherapy
Every month we try and update this database with for hormonotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) | NCT01078545 | Advanced Prosta... Lower Urinary T... | Leuprolide acet... | 50 Years - | Abbott | |
| Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy | NCT00868868 | Prostate Cancer | 18 Years - | Groupe de recherche en Urologie de la Mauricie | ||
| Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep | NCT03420105 | Breast Cancer Memory Disorder... | Neuropsychologi... Hormonotherapy | 18 Years - 70 Years | Centre Francois Baclesse | |
| Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer | NCT01399086 | Breast Cancer | Fulvestrant | 18 Years - | Hellenic Oncology Research Group | |
| SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer | NCT00272740 | Breast Neoplasm... | Fulvestrant | - | AstraZeneca | |
| SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer | NCT00272740 | Breast Neoplasm... | Fulvestrant | - | AstraZeneca | |
| Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects | NCT01183832 | Breast Cancer | - | Centre Oscar Lambret | ||
| Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment | NCT01564056 | Breast Cancer | HORMONOTHERAPY CHEMOTHERAPY th... | 70 Years - | UNICANCER | |
| Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer | NCT01399086 | Breast Cancer | Fulvestrant | 18 Years - | Hellenic Oncology Research Group | |
| E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer. | NCT04228432 | Breast Cancer | Dedicated and c... | 18 Years - | Institut Claudius Regaud | |
| Evaluation of Sexual Quality of Life for Breast Cancer | NCT04200001 | Breast Cancer Cancer Quality of Life | Quality of life | 18 Years - 51 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Feasibility Study: Yoga Educational Project | NCT04001751 | Breast Cancer | educational yog... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer | NCT00272740 | Breast Neoplasm... | Fulvestrant | - | AstraZeneca | |
| Evaluation of Sexual Quality of Life for Breast Cancer | NCT04200001 | Breast Cancer Cancer Quality of Life | Quality of life | 18 Years - 51 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep | NCT03420105 | Breast Cancer Memory Disorder... | Neuropsychologi... Hormonotherapy | 18 Years - 70 Years | Centre Francois Baclesse |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
